The risk of perinatal morbidity and mortality increase in pregnancies beyond 41 gestational 4 5 weeks [1, 2] . The underlying mechanism is assumed to be aging of the placenta and 7 8 subsequent relative placental insufficiency, thus predisposing the fetus to hypoxia. However, 9 10 it is challenging to identify specific pregnancies at risk of intrapartum fetal compromise and 12 13 adverse outcomes. Numerous methods, such as fetal Doppler parameters and computerized 14 15 cardiotocography, are used to monitor placental function and fetal wellbeing. Nevertheless, EPO is used as a biomarker of chronic fetal hypoxia. We hypothesized that an evaluation of 39 40 amniotic fluid EPO level prior to labor could be used to identify the individuals at risk of gestational age fetus in a non-diabetic mother, unstable presentation, polyhydramnios, or diagnosed by using oral glucose tolerance test, smoking, the main indication for cesarean 14 15 section) and short-term neonatal outcomes (Apgar score at one and five minutes, umbilical 17 18 artery pH and BE, birthweight, and gestational age) were obtained from the hospital charts.
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The EPO levels were measured using a solid-phase immunochemiluminometric assay The mode of the delivery is known to affect umbilical cord serum EPO level, with higher 7 8 values occurring following vaginal birth as compared to planned cesarean sections [7, 14] . No 9 10 such difference was found in the current study. This is biologically plausible, considering the 12 13 exposure of all the neonates to delivery contractions. Umbilical cord serum EPO levels did 14 15 not correlate with the duration of the labor nor that of the second stage of the labor in the Umbilical cord serum EPO levels correlated with gestational age, but the difference in this 25 26 regard between term and prolonged pregnancies was not significant. This is reasonable, The authors declare no conflicts of interest. 
